Elanco Animal Health (ELAN) IPO Opens 34% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Gabelli Starts Elanco Animal Health (ELAN) at Buy Ahead of IPO
September 20, 2018 9:24 AM EDTGabelli analyst Kevin Kedra initiates coverage on Elanco Animal Health (NYSE: ELAN) with a Buy rating.
Kedra issues new coverage on ELAN which is scheduled to launch for IPO today with an expected price range of $20-$23 per share on the... More
Lilly's (LLY) Subsidiary Elanco Animal Health's (ELAN) IPO Prices at $24/Share
September 19, 2018 5:14 PM EDTElanco Animal Health Incorporated, a subsidiary of Eli Lilly and Company (NYSE: LLY), announced today the pricing of its initial public offering (IPO) of 62.9 million shares of its common stock at a price to the public of $24.00 per share. The shares are expected to begin trading... More
